Buspirone Hcl Tablet
NDC Package 72189-620-30
Package Information
Buspirone Hcl tablets is a medication used to treat anxiety. This formulation utilizes a tablet delivery system. Marketed by Direct_rx, this product is identified by NDC 72189-620 and is authorized under FDA application ANDA210907.
Identification & Billing
- RxCUI: 866018 - busPIRone HCl 15 MG Oral Tablet
- RxCUI: 866018 - buspirone hydrochloride 15 MG Oral Tablet
- RxCUI: 866018 - buspirone hydrochloride 15 MG (buspirone 13.7 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72189 - Direct_rx
- 72189-620 - Buspirone Hcl
- 72189-620-30 - 30 TABLET in 1 BOTTLE
- 72189-620 - Buspirone Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72189-620). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72189-620-30 identifies a specific commercial package of 30 tablet in 1 bottle of Buspirone Hcl, a human prescription drug labeled by Direct_rx. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains buspirone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Direct_rx on April 08, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat anxiety. It may help you think more clearly, relax, worry less, and take part in everyday life. It may also help you to feel less jittery and irritable, and may control symptoms such as trouble sleeping, sweating, and pounding heartbeat. Buspirone is a medication for anxiety (anxiolytic) that works by affecting certain natural substances in the brain (neurotransmitters).
How is this Direct_rx product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72189062030. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.